The STRIVE-ON Trial results will be presented as a poster on April 21, 2026. Details are as follows:

Session:    S21: Neurocritical Care
Date:    April 21, 2026
Time:    1:00 pm CT
Title:    Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage: a Prospective, Randomized Trial